Spectrum Pharmaceutical’s Access4Me
Spectrum Pharmaceuticals offers the Access4Me program to provide access and reimbursement support to patients who have been prescribed Rolvedon (Table).
Rolvedon Copay Assistance Program
The Rolvedon Copay Assistance Program may reduce out-of-pocket costs for patients with commercial insurance to as little as $0, up to a maximum annual benefit of $15,000 per 12-month enrollment period.
Rolvedon Patient Assistance Program
Patients who are uninsured or underinsured may be eligible to receive Rolvedon at no cost through the Patient Assistance Program.
First-Cycle Patient Support Program
New patients can receive their first-cycle dose of Rolvedon free of charge. When enrolling the patient, simply check First-Cycle Patient Support on the enrollment form. Access4Me will conduct the benefits investigation, communicate the results to your office, and confirm patient eligibility for the free dose. This program is limited to one free dose per patient.
To enroll your patient in the Access4Me program, visit Access4Me.